{"id":6581,"date":"2012-03-16T13:09:46","date_gmt":"2012-03-16T12:09:46","guid":{"rendered":"http:\/\/www.ethicalquote.com\/?p=6581"},"modified":"2012-03-16T13:13:04","modified_gmt":"2012-03-16T12:13:04","slug":"philips","status":"publish","type":"post","link":"https:\/\/www.covalence.ch\/index.php\/2012\/03\/16\/philips\/","title":{"rendered":"Philips and the World Association of Sleep Medicine join together to raise global awareness of the importance of sleep"},"content":{"rendered":"

\"\"<\/a>Royal Philips Electronics (NYSE: PHG, AEX: PHI) will join with the World Association of Sleep Medicine (WASM) as an official sponsor of World Sleep Day 2012, held on Friday, March 16. This year\u2019s theme \u2014 \u2018Breathe Easily, Sleep Well\u2019 \u2014 centers on raising awareness of sleep disorders that affect a person\u2019s breathing, such as obstructive sleep apnea (OSA).\u00c2\u00a0 \u201cThe effects of sleep disorders should not be underestimated,\u201d said Allan O\u2019Bryan, executive director of the World Association of Sleep Medicine. \u201cMost sleep disorders are treatable, yet far too many individuals do not seek professional help. Philips and WASM continue working to help those with sleep-disordered breathing manage their conditions and lead healthier lives.\u201d\u00c2\u00a0 \u201cPhilips is pleased to work with the World Association of Sleep Medicine for World Sleep Day 2012 to build awareness and understanding around disorders that affect the quality of sleep, including obstructive sleep apnea,\u201d said Dr. David White, chief medical officer for Philips Home Healthcare Solutions and a professor of sleep medicine at Harvard Medical School. \u201cPhilips offers a wide range of sleep-related products and solutions, from diagnostic tools through to patient-centered sleep therapy devices, to enhance the quality of sleep and improve the health and well-being of people around the world.\u201d\u00c2\u00a0 One of the most common sleep disorders, OSA affects approximately five to six percent of the adult population and two to three percent of children.\u00c2\u00a0 It is characterized by a narrowing or closing of the upper airway, which obstructs breathing during sleep. More than two-thirds of all people with sleep apnea are not diagnosed and if left untreated OSA can increase the risk of other serious chronic conditions such as diabetes and heart disease.\u00c2\u00a0 Philips is a pioneer in science-based sleep solutions, which are a strategic element of the company\u2019s commitment to provide innovative solutions for the home. Through Philips Respironics, a global leader in the sleep and respiratory markets, Philips provides medical sleep products, especially for people suffering from OSA and those who seek to improve their quality of sleep. To educate people on the risks, diagnosis and treatment options for OSA, Philips Respironics launched an OSA educational program on featuring an interactive OSA risk assessment “sleep quiz.” More…<\/a><\/p>\n

News selected by Covalence | Country: Global | Company: Philips | Source: Philips<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Royal Philips Electronics (NYSE: PHG, AEX: PHI) will join with the World Association of Sleep Medicine (WASM) as an official sponsor of World Sleep Day 2012, held on Friday, March 16. This year\u2019s theme \u2014 \u2018Breathe Easily, Sleep Well\u2019 \u2014 centers on raising awareness of sleep disorders that affect a person\u2019s breathing, such as obstructive…<\/p>\n","protected":false},"author":665,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"wds_primary_category":0,"wds_primary_post_series":0,"footnotes":""},"categories":[1],"tags":[100],"post_series":[],"class_list":["post-6581","post","type-post","status-publish","format-standard","hentry","category-news","tag-philips","entry","no-media"],"_links":{"self":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts\/6581","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/users\/665"}],"replies":[{"embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/comments?post=6581"}],"version-history":[{"count":0,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts\/6581\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/media?parent=6581"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/categories?post=6581"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/tags?post=6581"},{"taxonomy":"post_series","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/post_series?post=6581"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}